Status:
TERMINATED
Longitudinal Study of Symptoms in Colorectal Cancer
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
AstraZeneca
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this research study is to learn more about the pain and/or other symptoms that patients may experience within five years from CRC diagnosis. Researchers also want to learn how genetic diff...
Detailed Description
If you agree to take part in this study, you will complete 5 questionnaires during a regularly scheduled visit. The questionnaires are designed to measure pain and other symptoms, your mood, and your ...
Eligibility Criteria
Inclusion
- Patients with colorectal cancer meeting one of the following criteria: 1. naive to oxaliplatin or to any microtubule stabilizing agents (e.g. Taxol, Abraxane, Ixabepilone) but scheduled for combined oxaliplatine chemotherapy (longitudinal study cohort 1); or 2. during first 5 years from colorectal cancer diagnosis (cross-sectional study cohort). This second cohort may include patients with colorectal cancer from the original 12-month study (the longitudinal cohort), both those who completed the study and those who dropped out. It may also include new patients who did not participate in the longitudinal phase of the study.
- Patients \>= 18 years old.
- Patients who speak English or Spanish.
Exclusion
- Cohort 1 patients with a neuropathy score of 1 or greater on the NCI's Common Terminology Criteria (CTCv3.0).
- Patients who do not understand the intent of the study.
- Cohort 1 patients unable to use the interactive voice response (IVR) system due to physical limitations (e.g., hearing impairment).
- Cohort 1 patients with a history of inflammatory bowel disease.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 27 2018
Estimated Enrollment :
509 Patients enrolled
Trial Details
Trial ID
NCT00777192
Start Date
August 1 2008
End Date
December 27 2018
Last Update
May 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030